Legal & General Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$854K Sell
30,858
-9,071
-23% -$251K ﹤0.01% 2282
2025
Q1
$887K Sell
39,929
-1,338
-3% -$29.7K ﹤0.01% 2227
2024
Q4
$816K Sell
41,267
-4,137
-9% -$81.8K ﹤0.01% 2305
2024
Q3
$1.13M Buy
45,404
+1,502
+3% +$37.5K ﹤0.01% 2187
2024
Q2
$820K Buy
43,902
+17,907
+69% +$334K ﹤0.01% 2261
2024
Q1
$513K Buy
25,995
+927
+4% +$18.3K ﹤0.01% 2416
2023
Q4
$440K Buy
25,068
+944
+4% +$16.6K ﹤0.01% 2510
2023
Q3
$419K Buy
24,124
+55
+0.2% +$955 ﹤0.01% 2500
2023
Q2
$339K Buy
24,069
+11,644
+94% +$164K ﹤0.01% 2582
2023
Q1
$134K Buy
12,425
+713
+6% +$7.67K ﹤0.01% 2715
2022
Q4
$175K Buy
11,712
+850
+8% +$12.7K ﹤0.01% 2664
2022
Q3
$139K Buy
10,862
+148
+1% +$1.89K ﹤0.01% 2730
2022
Q2
$103K Buy
10,714
+2,162
+25% +$20.8K ﹤0.01% 2850
2022
Q1
$85K Hold
8,552
﹤0.01% 2904
2021
Q4
$101K Hold
8,552
﹤0.01% 2906
2021
Q3
$97K Buy
8,552
+4,732
+124% +$53.7K ﹤0.01% 2854
2021
Q2
$53K Sell
3,820
-601
-14% -$8.34K ﹤0.01% 2929
2021
Q1
$82K Buy
4,421
+130
+3% +$2.41K ﹤0.01% 2670
2020
Q4
$76K Hold
4,291
﹤0.01% 2659
2020
Q3
$66K Buy
4,291
+29
+0.7% +$446 ﹤0.01% 2598
2020
Q2
$108K Buy
4,262
+1,985
+87% +$50.3K ﹤0.01% 2504
2020
Q1
$29K Sell
2,277
-815
-26% -$10.4K ﹤0.01% 2774
2019
Q4
$34K Buy
3,092
+537
+21% +$5.91K ﹤0.01% 2992
2019
Q3
$22K Hold
2,555
﹤0.01% 3104
2019
Q2
$35K Buy
2,555
+565
+28% +$7.74K ﹤0.01% 2938
2019
Q1
$36K Buy
1,990
+1,010
+103% +$18.3K ﹤0.01% 2839
2018
Q4
$28K Hold
980
﹤0.01% 2937
2018
Q3
$25K Buy
+980
New +$25K ﹤0.01% 3118